Literature DB >> 7669821

Tardive dystonia. Prevalence, risk factors, and comparison with tardive dyskinesia in a population of 200 acute psychiatric inpatients.

M Raja1.   

Abstract

In a population of 200 consecutive inpatients with a history of at least 3 months' total cumulative neuroleptic exposure, the prevalence of tardive dystonia (TDt) was 4%, higher than previously reported. The prevalence of tardive dyskinesia (TDk) was 22%. Patients with TDt did not differ in demographic or clinical variables from nondyskinetic patients. In comparison with patients with TDk, patients with TDt were significantly younger, had a more severe movement disorder, and had received neuroleptics for the first time fewer years before. Patients with TDk were significantly older than patients without tardive disorders, both when they were examined and when they had started their first neuroleptic treatment. Furthermore, they had started their first neuroleptic treatment more years before. These results support the distinction between TDt and TDk, and suggest that the previously reported prevalence of TDt might have been underestimated.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7669821     DOI: 10.1007/bf02193087

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  60 in total

Review 1.  The dystonias.

Authors:  C D Marsden; N P Quinn
Journal:  BMJ       Date:  1990-01-20

2.  Mini-compendium of rating scales for states of anxiety depression mania schizophrenia with corresponding DSM-III syndromes.

Authors:  P Bech; M Kastrup; O J Rafaelsen
Journal:  Acta Psychiatr Scand Suppl       Date:  1986

3.  High-dose bromocriptine in a case of tardive dystonia.

Authors:  D J Luchins; M Goldman
Journal:  Biol Psychiatry       Date:  1985-02       Impact factor: 13.382

4.  Sex differences in schizophrenia: timing or subtypes?

Authors:  R R Lewine
Journal:  Psychol Bull       Date:  1981-11       Impact factor: 17.737

5.  Prevalence of tardive dyskinesia, tardive dystonia, and respiratory dyskinesia among Chinese psychiatric patients in Hong Kong.

Authors:  H Chiu; P Shum; J Lau; L Lam; S Lee
Journal:  Am J Psychiatry       Date:  1992-08       Impact factor: 18.112

6.  Effect of diagnostic criteria on the ratio of male to female schizophrenic patients.

Authors:  R Lewine; D Burbach; H Y Meltzer
Journal:  Am J Psychiatry       Date:  1984-01       Impact factor: 18.112

7.  Tardive dyskinesia outcomes: clinical and pharmacologic correlates of remission and persistence.

Authors:  R Cavallaro; M G Regazzetti; E Mundo; V Brancato; E Smeraldi
Journal:  Neuropsychopharmacology       Date:  1993-05       Impact factor: 7.853

8.  Cognitive dysfunction, negative symptoms, and tardive dyskinesia in schizophrenia. Their association in relation to topography of involuntary movements and criterion of their abnormality.

Authors:  J L Waddington; H A Youssef; C Dolphin; A Kinsella
Journal:  Arch Gen Psychiatry       Date:  1987-10

9.  Gender and the course of schizophrenia: differences in treated outcomes.

Authors:  M C Angermeyer; L Kühn; J M Goldstein
Journal:  Schizophr Bull       Date:  1990       Impact factor: 9.306

10.  An unusual cluster of tardive dyskinesia in schizophrenia: association with cognitive dysfunction and negative symptoms.

Authors:  J L Waddington; H A Youssef
Journal:  Am J Psychiatry       Date:  1986-09       Impact factor: 18.112

View more
  7 in total

1.  Antipsychotic-induced movement disorders: evaluation and treatment.

Authors:  Maju Mathews; Sylvia Gratz; Babatunde Adetunji; Vinu George; Manu Mathews; Biju Basil
Journal:  Psychiatry (Edgmont)       Date:  2005-03

Review 2.  Drug-induced Pisa syndrome (pleurothotonus): epidemiology and management.

Authors:  Toshihito Suzuki; Hisashi Matsuzaka
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

3.  Effects of chronic haloperidol and/or clozapine on oxidative stress parameters in rat brain.

Authors:  Fabiano R Agostinho; Luciano K Jornada; Nadja Schröder; Rafael Roesler; Felipe Dal-Pizzol; João Quevedo
Journal:  Neurochem Res       Date:  2007-03-31       Impact factor: 3.996

4.  Tardive dystonia. Prevalence, risk factors and clinical features.

Authors:  M Raja; A Azzoni
Journal:  Ital J Neurol Sci       Date:  1996-12

5.  Managing antipsychotic-induced acute and tardive dystonia.

Authors:  M Raja
Journal:  Drug Saf       Date:  1998-07       Impact factor: 5.606

Review 6.  Movement disorders in psychiatric patients.

Authors:  Laura Perju-Dumbrava; Peter Kempster
Journal:  BMJ Neurol Open       Date:  2020-12-01

7.  Globus Pallidus Internus Deep Brain Stimulation for Dystonic Opisthotonus in Adult-Onset Dystonia: A Personalized Approach.

Authors:  Kantharuby Tambirajoo; Luciano Furlanetti; Michael Samuel; Keyoumars Ashkan
Journal:  Front Hum Neurosci       Date:  2021-06-10       Impact factor: 3.169

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.